Alkyl Amines Chemicals Limited

NSE:ALKYLAMINE.NS

2055.95 (INR) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32013 Q42013 Q32013 Q12012 Q42012 Q32012 Q22012 Q1
Revenue 4,148.93,996.93,566.23,220.53,521.54,097.94,114.63,885.24,088.74,734.84,064.463,766.63,486.93,918.063,628.1243,238.8572,912.6832,451.5212,149.3712,569.1112,349.7082,662.3052,232.6852,126.692,181.3911,781.4191,628.9751,531.2651,223.8741,021.411,027.926950.778935.369883.1820.5
Cost of Revenue 2,712.92,552.62,221.51,6871,912.32,265.62,207.21,982.92,083.52,323.12,553.6792,084.11,893.92,001.9991,777.231,266.9231,239.1981,081.3261,188.2481,146.1891,148.6351,471.1011,536.4141,157.1071,131.753898.535981.621851.849383.333676.295705.182274.081668.484602.2548.3
Gross Profit 1,4361,444.31,344.71,533.51,609.21,832.31,907.41,902.32,005.22,411.71,510.7811,682.51,5931,916.0611,850.8941,971.9341,673.4851,370.195961.1231,422.9221,201.0731,191.204696.271969.5831,049.638882.884647.354679.416840.541345.115322.744676.697266.885280.9272.2
Gross Profit Ratio 0.3460.3610.3770.4760.4570.4470.4640.490.490.5090.3720.4470.4570.4890.510.6090.5750.5590.4470.5540.5110.4470.3120.4560.4810.4960.3970.4440.6870.3380.3140.7120.2850.3180.332
Reseach & Development Expenses 00000066.8810000000000041.40900035.033000000000000
General & Administrative Expenses 00000000000000000000000000000000000
Selling & Marketing Expenses 000000000000000000000000000000000089.6
SG&A 880.8830.3830.3704.8895.2251.1910.1969.2950.6984.8943.4805616.9562.754277.627239.828213.024199.169174.264190.379169.567166.896134.083135.37139.832126.1380000000089.6
Other Expenses 047.22646.223.554.830.543.523.342-98.51345.741.822.3-53.916.59827.05811.806-37.18921.6722.96813.326-30.74127.3040.6270-25.73816.085-23.60918.6957.139727.953145.016160.551.5
Operating Expenses 880.8830.3830.31,105.21,251.71,214.31,260.41,311.71,3041,371.1882.7191,095.6915.4884.415532.39816.687792.995666.576344.411765.202689.045663.653352.71640.809613.395568.85257.145448.296600.671167.21169.824563.852145.016160.5141.1
Operating Income 555.2614514.4474.5381618677.5634.1724.51,040.6619.4586.9677.61,031.6461,318.5041,155.247907.548715.425616.712657.72512.028540.877343.561328.774436.243313.786390.209231.1298.989196.6130.734107.946121.869120.4131.1
Operating Income Ratio 0.1340.1540.1440.1470.1080.1510.1650.1630.1770.220.1520.1560.1940.2630.3630.3570.3120.2920.2870.2560.2180.2030.1540.1550.20.1760.240.1510.0810.1920.1270.1140.130.1360.16
Total Other Income Expenses Net 88.145.119-11.2-16.745.9-6.4-7.7-1133.926.635.731.811.441-57.2662.892-16.185-19.235-4.588162.01-6.64-36.332-17.983-8.998-28.051-39.112-30.895-0.599-22.416-28.36-22.186-33.132-30.396-27.3-29.2
Income Before Tax 643.3659.1533.4463.3364.3663.9671.1626.4713.51,074.5646.047622.6709.41,043.0871,261.2381,158.139891.363696.19612.124819.73505.388504.545325.578319.776408.192274.674359.314230.521187.748168.24130.73474.81491.47393.1101.9
Income Before Tax Ratio 0.1550.1650.150.1440.1030.1620.1630.1610.1750.2270.1590.1650.2030.2660.3480.3580.3060.2840.2850.3190.2150.190.1460.150.1870.1540.2210.1510.1530.1650.1270.0790.0980.1050.124
Income Tax Expense 168.7170.4148.912991.9166.2184.5169.4189.4255.7182.182163.8168.5257.684335.251313.248236.643168.377118.982215.598-43.915153.616126.45398.691141.33798.023109.26678.29663.67756.3864233.27229.3126.331.1
Net Income 474.6488.7384.331334.3272.4497.7486.553457524.1818.8463.865458.8540.9785.403925.987844.891654.72527.813493.142604.132549.303350.929199.125221.085266.855176.651250.048152.225123.724111.85488.73442.37662.16366.870.8
Net Income Ratio 0.1140.1220.1080.1040.0770.1210.1180.1180.1280.1730.1140.1220.1550.20.2550.2610.2250.2150.2290.2350.2340.1320.0890.1040.1220.0990.1540.0990.1010.110.0860.0450.0660.0760.086
EPS 9.289.557.526.545.339.749.528.9410.2616.039.088.9810.5915.3918.1516.5612.8410.359.6715.1210.576.883.914.365.233.464.92.982.432.191.740.831.221.311.39
EPS Diluted 9.279.557.516.535.329.729.518.9310.24169.078.9710.5715.3518.1516.512.810.329.6715.0810.546.863.914.355.223.464.92.982.432.191.740.831.221.311.39
EBITDA 826.9790.8688.7642.3506.3794.6793.3740.6836.21,200.3750.417711.6796.41,129.4151,332.4311,247.501979.677785.621675.349759.26596.372604.871408.615413.086503.235352.41415.89286.214224.174225.054186.06116.904147.433144.8156.4
EBITDA Ratio 0.1990.1980.1930.1990.1440.1940.1930.1910.2050.2540.1850.1890.2280.2880.3670.3850.3360.320.3140.2960.2540.2270.1830.1940.2310.1980.2550.1870.1830.220.1810.1230.1580.1640.191